Kevin D. Ballard

Metastable decomposition of peptide [M + H]+ ions via rearrangement involving loss of the C-terminal amino acid residue

A novel fragmentation of metastable peptide [M + H]+ ions is described. Loss of the C-terminal amino acid residue is accomqanied by retention of one of the carboxyl oxygens, as judged by 18O-labeling. The retained 8O label is located at the new C-terminus. Sequential mass spectrometric analyses indicate that the structure of the first-generation product ion is indistinguishable from that of the [M + H]+ ion of the peptide with one fewer amino acid residues. Thus, for example, the metastable decompositions of ions of m/z 904 are similar whether they correspond to des-Arg9-bradykinin [M + H]+ ions or to fragments derived from bradykinin [M + H]+ ions. No corresponding rearrangements have been observed for peptides with C-terminal amide or ester functions. The mechanism of this fragmentation may be considered to be analogous to that previously suggested for fragmentations of [M + alkali metal cation]+ ions. For the examples of bradykinin and related peptides, the rearrangement is strongly promoted when arginine is the amino acid residue lost. The same fragmentation is also favored by the presence of an arginine residue at or near the N-terminus. The strong influence of peptide amino acid composition, including residues remote from the C-terminus, on the prevalence of this fragmentation suggests mechanistic complexities that require further elucidation.

Sequential mass spectrometry applied to the study of the formation of “internal” fragment ions of protonated peptides

Abstract “Internal” fragment ions of protonated peptides arise by charge retention on a portion of the structure excised from the peptide chain. Their formation appears to be favored by the extented time scale and multiple collision conditions associated with decomposition experiments which use the r.f.-only quadrupole of a hybrid sector/quadrupole mass spectrometer. Sequential product ion scanning and reaction intermediate scanning techniques of MS—MS—MS were used to probe these necessarily multistep fragmentations. With an instrument of BEqQ geometry, mass-analyzed ion kinetic energy spectrometry analyses were used to determine the population of candidate intermediates available for subsequent decomposition to internal fragments in the r.f.-only quadrupole. Reaction intermediate scanning then indicates the relative quantitative significance of competing pathways. In the examples studied, certain Y″-type ions show a high inherent tendency to fragment further to give internal fragments, consistent with the formal equivalence of these intermediates to protonated truncated peptides. Internal fragments can also arise, however, through a number of multistep pathways which can predominate in situations where the requisite intermediates are formed in high abundance.

Dehydration of peptide [M + H]+ ions in the gas phase

The loss of water from protonated peptides was studied using [18O]-labeling of the C-terminal carboxyl group. The structures (including the location of the isotopic label) of first-generation product ions were examined by sequential product ion scanning (MS3 and MS4) using a hybrid sector/quadrupole mass spectrometer. Water loss may involve carboxylic acid groups, side-chain hydroxyls, or peptide backbone oxygens. Although one of these three pathways often predominates, more than one dehydration route can be operative for a single peptide structure. When peptide backbone oxygen is lost, the dehydration can occur at one or two primary sites along the backbone, with the location of the site(s) varying among peptides. When water loss involves the C-terminal carboxyl group, the resulting ion may undergo extensive intraionic oxygen isotope exchange. This evidence for complex intraionic interactions further emphasizes the significance of gas-phase conformation in determining the fragmentations of peptide ions.

An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument.

An analytical strategy is described for analyzing quaternary ammonium neuromuscular blocking agents in a wide variety of biological specimens in a forensic setting. Neuromuscular blocking agents such as succinylcholine, pancuronium, and tubocurarine, often used as paralytic agents during surgery, are occasionally suspected as paralytic poisoning agents involved in suspected homicide and suicide cases. Because suspicion in such cases can develop slowly, the age, nature, and quality of available specimens varies greatly. The compounds are challenging analytically because of their simultaneous precharged yet lipophilic character. An analytical strategy has been devised for extracting these compounds from complex matrices using a combination of a modified Bligh and Dyer liquid-liquid extraction (used in reverse) followed by reverse-phase ion pairing solid-phase extraction using heptafluorobutyric acid as an ion pairing reagent. Final analysis is by LC-MS/MS using a tandem quadrupole orthogonal acceleration time of flight instrument (Q-TOF) with repetitive product ion scanning at high resolution. Native and spiked specimens are compared for both quantitative and especially qualitative purposes. The method has been applied to a wide variety of fluid and tissue specimen types, including numerous specimens from exhumation autopsies. For most specimens, detection limits are in the 2 to 10 ng/g range. Succinylmonocholine has been demonstrated to be present at low levels in normal posthumous kidney and liver. The Q-TOF is an excellent platform for forensic analytical investigations. This analytical strategy should also be applicable to other problematic analytes and sample matrices.

Multiple scan modes in the hybrid tandem mass spectrometric screening and characterization of the glutathione conjugate of 2-furamide.

The glutathione conjugate of 2-furamide has been screened for and structurally characterized by tandem mass spectrometry (MS(MS) by using a hybrid instrument of BEqQ design. Mass spectrometry experiments employed fast atom bombardment (FAB) ionization of a crude bile extract from a rat dosed with a 1:1 mixture of unlabeled and [ 13C12-furamide. Initial screening for glutathione conjugates employed constant neutral loss scanning to detect the loss of 129 u, corresponding to the loss of the γ-glutamyl moiety of the conjugates. By direct comparison with control bile, [M + H] + ions of m/z 417 and 418 were readily identified as candidate ions corresponding to the glutathione conjugates of unlabeled and 13C-labeled 2-furamide. Complementary screening information was generated by using a methylated bile extract, with constant neutral loss scanning to detect the loss of the methylated γ-glutamyl moiety (143 u). An alternative screening procedure employing parent ion scanning to detect the sodium adducts of methylated glutathione conjugates was also developed. Structural information was generated by frrst-generation product ion scanning of the protonated and sodium cationized forms of the candidate species, both native and derivatized. This provided a body of internally consistent evidence that the conjugate retains the pseudoaromatic furan ring system without ring hydroxylation. The utility of sequential mass spectrometry (MS(MS(MS) capability of the hybrid instrument in the analysis of complex biological mixtures was also demonstrated. Using the bile extract, first-generation product ions that formed in either the first or second field-free region of the double-focusing portion of the instrument were subsequently collisionally activated in the rf-only quadrupole followed by mass analysis of the second-generation product ions. Structural information so provided for the glutathione conjugate of 2-furamide further substantiated its retention of the pseudoaromatic furan ring system and facilitated plausible assignment of structures to ionic species generated through multiple decomposition events.

Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.

Thirty-three patients with mild-to-moderate essential hypertension received either placebo or fenoldopam, a selective dopamine-1 agonist, by intravenous infusion at a fixed infusion rate ranging from 0.1 to 0.8 microg/kg/min for 48 h during a double-blind, placebo-controlled, randomized inpatient clinical trial. Blood pressure and heart rate were measured every 15 min for 24 h before, during, and 24 h after the 48-h drug infusion. Plasma concentrations of racemic fenoldopam were measured at frequent intervals during and for 24 h after fenoldopam infusion. In the 26 patients who received fenoldopam, there were dose-dependent reductions in systolic and diastolic blood pressure, which usually reached a nadir within 2 h of beginning infusion and were significant even at the lowest dose studied (-9 and -9 mm Hg for systolic and diastolic blood pressure, respectively, at 24 h for the dose of 0.04 microg/kg/min, P < .05). There were associated increases in heart rate that were greater in the first than in the last 24 h of drug infusion. Compared to the average 24-h control blood pressure, maximum mean reductions in systolic and diastolic blood pressures of 33 and 21 mm Hg, respectively, were noted in patients receiving fenoldopam at 0.8 microg/kg/min and occurred 4 and 1 h, respectively, after beginning infusion. Tolerance to the blood pressure lowering effects of the drug developed slowly during the 48 h of drug infusion; the half-life for this effect was 60 h. No serious adverse clinical effects were noted in any patient. These results demonstrate that fenoldopam is effective in reducing blood pressure of patients with mild-to-moderate hypertension at doses as low as 0.04 microg/kg/min, is well tolerated at doses up to 0.8 microg/kg/min, maintains most of its antihypertensive efficacy throughout 48 h of continuous, constant rate infusion, and produces neither prolonged pharmacodynamic effects nor rebound hypertension when discontinued. The pharmacodynamic effects of the drug are best predicted by pharmacokinetics of racemic and R-fenoldopam.

Sustained Hemodynamic Effects of the Selective Dopamine-1 Agonist, Fenoldopam, during 48-Hour Infusions in Hypertensive Patients: A Dose-Tolerability Study

Eight patients with stage I‐II hypertension received a continuous IV infusion of the selective dopamine‐1 agonist, fenoldopam, for up to 48 hours at rates from 0.4 to 1.9 μg/kg/min. Hemodynamics and clinical symptoms during infusion were compared to the same parameters in the 24‐hour periods before and after infusion. Fenoldopam lowered blood pressure and increased heart rate. Greatest changes occurred during the first 12 hours of infusion and gradually returned toward preinfusion values throughout the remaining 36 hours in the six patients who completed 48 hours of infusion. Fenoldopam was discontinued within 2 hours of starting the infusion in two patients who received drug rates of 0.9 μg/kg/min and 1.9 μg/kg/min because of precipitous bradycardia. Clinical symptoms noted at fenoldopam doses higher than 0.8 μg/kg/min were headache, dizziness, diaphoresis, nausea and vomiting, and restlessness. In this pilot study, fenoldopam effectively reduced blood pressure in patients with stage I‐II hypertension for up to 48 hours, but fixed‐dose infusion rates above 0.8 μg/kg/min were associated with a high frequency of clinically significant and often intolerable adverse effects.

Hybrid Tandem Mass Spectrometry

The development of hybrid sector/quadrupole instruments for tandem mass spectrometry is described. The operational modes of these instruments are illustrated by MS/MS and MS/MS/MS analyses of peptides, xenobiotic metabolites and other compounds of biological importance.The versatility of operation (with respect to scan modes and the conditions utilized for collisionally activated decomposition) is a particular advantage of hybrid instruments.

Origin of the tailing signal on the low-energy side of the main beam in mass-analyzed ion kinetic energy spectra

The tailing signal on the low-energy side of the precursor ion signal observed during fast atom bombardment (FAB) mass-analyzed ion kinetic energy spectrometric (MIKES) analyses is due largely to ions of higher m/z value than the chosen precursor. The majority of these ions are independent, unfragmented species that emerge from the ion source with less than the full amount of kinetic energy predicted by the source potential. The tailing precursor ion signal observed under helium collision-activated decomposition conditions is too short to account for the protracted MIKES tail (as judged from mass-to-charge ratio-deconvoluted MIKES analyses performed on a BEqQ hybrid instrument), and a tailing precursor signal is not observed under unimolecular decomposition conditions. Measurements of the mass-to-charge ratios of the ionic species comprising the MIKES tail demonstrated that ions higher in mass-to-charge ratio than the chosen precursor are present throughout the tail, with the mass-to-charge ratio increasing as kinetic energy decreases. These ions possess the same momentum as the chosen precursor, and thus were formed prior to the magnetic field. The existence of intact, source-formed [M + H]+ ions with reduced kinetic energy was demonstrated through several types of tandem mass spectrometric experiments. These [M + H]+ ions with reduced kinetic energy do not appear to have undergone collisional deceleration, because they do not possess increased internal energy (as judged by observation of their fragmentation patterns). The kinetic energy profiles of unfragmented FAB-desorbed ions were determined and found to exhibit a tailing character similar in appearance to that of the MIKES tail. The population of ions emerging from the source under FAB conditions thus incorporates the characteristics necessary to account for the MIKES tail, namely, the presence of ions of a mass-to-charge ratio higher than the chosen precursor (due to matrix and other background ions), which possess reduced kinetic energy such that their momentum is identical to that of the selected precursor. These ions may arise via desolvation and declustering processes in the acceleration region of the ion source, or via FAB or chemical ionization processes in regions removed from the FAB target.

Prediction of artifact peak intensity in linked scans for dissociations occurring in the first field-free region of sector mass spectrometers

Linked scans are commonly used on double-focusing mass spectrometers to obtain tandem mass spectrometry (MS/MS) spectra. The appearance of artifact peaks in linked scan MS/MS spectra from dissociations occurring in the first field-free region are a result of poor parent ion resolution, and they often can complicate the interpretation of the MS/MS spectra. The kinetic energy release associated with dissociation of ions of similar m/z to the “selected” parent ion is the main factor in determining the intensity of artifact peaks. A means of predicting the intensities of these artifact peaks in product ion and constant neutral loss scans is presented here. The method requires straightforward calculations based on Lacey-Macdonaldion intensity diagrams. The exact calculations require knowledge of the kinetic energy release of a particular dissociation, the kinetic energy spread of the main beam, and the parent ion and product ion mass-to-charge ratios. Adequate predictions, however, can be made by assuming a general kinetic energy release for any given reaction and a typical instrument energy resolution. Theoretical predictions are in good agreement with experimental data obtained from the product ion scans of unlabeled and isotopically labeled tirilazad and unlabeled and labeled leucine enkephalin methyl ester. There is also excellent agreement between experiment and theory in the constant neutral loss scans of rubidium bromide clusters.